Financiere de Tubize (STU:FTD) EBIT: €93.95 Mil (TTM As of Dec. 2025)

What is Financiere de Tubize EBIT?

Financiere de Tubize STU:FTD +0.84% 38 EBIT is €93.95 Mil as of Dec. 2025. GuruFocus rates STU:FTD with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

Financiere de Tubize's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €-2.34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €93.95 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Financiere de Tubize's annualized ROC % for the quarter that ended in Dec. 2025 was -0.17%. Financiere de Tubize's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -312,533.33%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Financiere de Tubize's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.97%.

Financiere de Tubize (STU:FTD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Financiere de Tubize's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

	ROC % (Q: Dec. 2025 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2025 )	+	Invested Capital (Q: Dec. 2025 ))	/ count )
=	-3.416 * ( 1 - 0% )	/	( (1932.671	+	1980.839)	/ 2 )
=	-3.416	/	1956.755
=	-0.17 %

where

	Invested Capital		(Q: Jun. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1936.345	-	0.25	-	( 3.703	-	max(0, 0.367	-	3.791	+	3.703	))
=	1932.671

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1934.139	-	0.298	-	( 1.268	-	max(0, 48.579	-	1.581	+	1.268	))
=	1980.839

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Financiere de Tubize's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2025 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2025		Q: Dec. 2025
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-4.688	/	( ( (0.002 + max(-0.366, 0))	+	(0.001 + max(-48.579, 0)) )	/	2 )
=	-4.688	/	( ( 0.002	+	0.001 )	/	2 )
=	-4.688	/	0.0015
=	-312,533.33 %

where Working Capital is:

	Working Capital		(Q: Jun. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.00099999999999989)	-	(0.25	+	0	+	0.117)
=	-0.366

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.298	+	0	+	48.281)
=	-48.579

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Financiere de Tubize's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2025 )
	=	93.947	/	9684.673
	=	0.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Financiere de Tubize EBIT Related Terms

Financiere de Tubize EBIT Historical Data

* Premium members only.

The historical data trend for Financiere de Tubize's EBIT can be seen below:

Financiere de Tubize EBIT Chart

Financiere de Tubize Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT

Get a 7-Day Free Trial

84.92

86.89

90.49

92.60

93.95

Financiere de Tubize Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
EBIT	Get a 7-Day Free Trial															-1.68	94.58	-1.98	96.29	-2.34

STU:FTD vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Financiere de Tubize's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Financiere de Tubize EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's EV-to-EBIT falls into.

Save Embed

38GF Score

Financiere de Tubize SA STU:FTD

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Financiere de Tubize EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €93.95 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of €93.95 Mil mean?

Financiere de Tubize (STU:FTD) has a EBIT of €93.95 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Financiere de Tubize.

Is Financiere de Tubize's EBIT too high?

Financiere de Tubize's current EBIT is €93.95 Mil. Overall, Financiere de Tubize has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.

How does Financiere de Tubize's EBIT compare to VRTX and REGN?

Financiere de Tubize's EBIT of €93.95 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Biotechnology company?

A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Financiere de Tubize. Financiere de Tubize's current EBIT is €93.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Financiere de Tubize stock overvalued right now?

Financiere de Tubize (STU:FTD) has a current EBIT of €93.95 Mil. The current EBIT is €93.95 Mil. Financiere de Tubize's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Financiere de Tubize (STU:FTD), the current EBIT is €93.95 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Financiere de Tubize Business Description

Industry Healthcare Biotechnology

Comparable Companies XBRU:ONWD XBRU:HYL XBRU:ALEMS XBRU:CYAD XBRU:OXUR XBRU:ARGX XBRU:UCB VRTX REGN XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270 RPRX BNTX INSM ROIV INCY

Other Exchanges 1TUB:Italy TUBb:UK 0D53:UK TUB:Belgium TUBI:Austria

Address Allee de la Recherche, 60, Brussels, BEL, 1070

Website https://www.financiere-tubize.be

Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

38GF Score

Get the complete analysis for STU:FTD

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€216.80

Price

View STU:FTD Analysis

See EBIT data for all stocks →